Not all cancers are the same, even if they originate in the same organ. Targeted therapy works by blocking the specific proteins, genes or pathways that fuel your particular cancer's growth. We arrange appropriate molecular profiling and genetic testing to identify actionable targets — such as EGFR, ALK, BRAF, HER2, BCR-ABL or c-KIT mutations — and then select the targeted agent that is most likely to be effective for your tumour profile. This personalised approach often means better disease control with a side-effect profile that is more manageable than traditional chemotherapy, allowing many patients to continue their daily activities during treatment.
